Medical experts came together to address matters concerning the different types of headaches commonly experienced today.

Japanese drugmaker Eisai Co. Ltd. said on Monday it had submitted a marketing authorization application in Japan for its Alzheimer’s drug lecanemab, which was recently granted accelerated ...

Merck & Co. and Eisai reported mixed results from a late-stage study of the cancer drugs Keytruda and Lenvima in patients with certain types of gastroesophageal cancer. Merck and Eisai on Friday ...

AUSTIN (KXAN)– The Hi How Are You Project has been teaching students how to be aware and manage their mental health for seven years. This month the project celebrates Austin’s Hi How Are You ...

E-2086 is under clinical development by Eisai and currently in Phase I for Narcolepsy. According to GlobalData, Phase I drugs for Narcolepsy have an 80% phase transition success rate (PTSR) indication ...

Lenvatinib mesylate is under clinical development by Eisai and currently in Phase II for Osteosarcoma. According to GlobalData, Phase II drugs for Osteosarcoma have a 13% phase transition success rate ...

The constraint has been a lack of good drugs to treat those patients. Eisai and Biogen, with Leqembi, and Eli Lilly, with Kisunla, have begun the process of establishing a drug arsenal for ...

The battle to become the best music streaming service for offering hi-res streams is well and truly underway. Gone are the days when all a streaming platform had to do was offer up low-quality Ogg ...

Which is what we have done for this issue of What Hi-Fi?. In February's magazine you will find five brilliant stereo systems based on Award-winning kit. It is always tempting to put “Award-winning ...

Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) (OTCPK:ESAIY) announced that the U.S. Food and Drug Administration (FDA) accepted a marketing application for an injectable version of their Alzheimer ...